Taurus Diagnostics uses artificial intelligence to advance cancer diagnostics.
Taurus Diagnostics utilises data-centric AI solutions to increase the accuracy of MRI while preventing unnecessary biopsies. Their data-centric AI algorithm has been trained on thousands of patient examples to find lesions concerning prostate cancer in a reproducible and generalizable manner, enabling physicians to identify patients most in need of a biopsy and will demonstrate locations of lesions.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2022 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |